Login
Search result (1-20 of 69)Download
|
Symbol
|
RMA72V | RMBQ5V | RMA7JV | RMBAIV | PKRRCH | ABUBTQ | RMAHCV | CMDBKB | RMAWUV | POARCH | POTRCH | Z0AQXZ | ACGFTQ | RMBV1V | RMALFV | MBUDJB | Z0AU9Z | RMACWV | RMAXAV | RMBEPV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible with European Knock-In | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible with European Knock-In | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti |
|
Underlying
|
Novartis AG / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Lonza Group N / Novartis AG / Roche PS / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Alcon / Lonza Group N / Ypsomed Hldg. AG | Nestlé S.A. / Novartis AG / Roche PS / Ypsomed Hldg. AG | Lonza Group N / Novartis AG / Roche PS / Ypsomed Hldg. AG | Alcon / Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Givaudan / Holcim/Amrize Basket / Nestlé S.A. / Ypsomed Hldg. AG | Bachem Hldg. AG / Ypsomed Hldg. AG | Sonova Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Straumann Hldg. AG / VAT Group / Ypsomed Hldg. AG | Bachem Hldg. AG / Lonza Group N / Sonova Hldg. AG / Ypsomed Hldg. AG | Lonza Group N / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Galderma Group AG / Sandoz Group AG / Ypsomed Hldg. AG | Lonza Group N / Straumann Hldg. AG / VAT Group / Ypsomed Hldg. AG | Lonza Group N / Novartis AG / Sandoz Group AG / Ypsomed Hldg. AG | Novo Nordisk AS (B) / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | Novartis AG / Roche PS / Straumann Hldg. AG / Ypsomed Hldg. AG |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
31.08.2026 | 17.11.2026 | 21.12.2026 | 30.12.2026 | 30.06.2026 | 30.12.2026 | 05.01.2027 | 17.07.2026 | 25.01.2027 | 31.07.2026 | 07.08.2026 | 19.08.2027 | 03.09.2026 | 01.03.2027 | 28.08.2026 | 29.06.2026 | 03.09.2027 | 31.03.2027 | 12.10.2026 | 07.12.2026 |
| Bid | 84.00 | 44.200 | 98.50 | 55.90 | 101.39 | 101.05 | 100.40 | 101.62 | 97.70 | 101.41 | 64.50 | - | 68.68 | 97.60 | 99.90 | - | - | 99.80 | 74.60 | 94.50 |
| Ask | - | - | 100.10 | - | - | 101.86 | 101.80 | - | 99.30 | - | - | - | - | 99.00 | 101.30 | - | - | - | - | - |
Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.
Your Bookmarks (0)